Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) that has emerged and rapidly spread across the world. The COVID-19 severity is associated to viral pneumonia with additional extrapulmonary complications. Hyperinflammation, dysfunctional immune r...

Descripción completa

Detalles Bibliográficos
Autores principales: Motta, Nadia Alice Vieira, Autran, Lis Jappour, Brazão, Stephani Correia, Lopes, Rosane de Oliveira, Scaramello, Christianne Brêtas Vieira, Lima, Gabriel Ferreira, Brito, Fernanda Carla Ferreira de
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768212/
https://www.ncbi.nlm.nih.gov/pubmed/33418248
http://dx.doi.org/10.1016/j.intimp.2020.107336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768212/
https://www.ncbi.nlm.nih.gov/pubmed/33418248
http://dx.doi.org/10.1016/j.intimp.2020.107336

Ejemplares similares